Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Start date: May 16, 2024 End date: May 19, 2024
Heart Rhythm will begin at1:00 PM ET on Thursday, May 16, and conclude at 3:00 PM ET on Sunday, May 19, 2024, at the Boston Convention & Exhibition Center in Boston, MA (originally Friday, May 17 to Sunday, May 19). View more
Author(s): Yaser Nemshah , Alex Clavijo , Gyanendra Sharma Added: 3 years ago
Amyloidosis is a heterogenous group of disorders that develops secondary to the deposition of abnormally folded proteins, amyloid fibrils, in the extracellular space. Amyloidosis is classified according to the type of the precursor protein that results in the formation of amyloid fibrils. It can be inherited or acquired, and can involve multiple organs, including the heart. Amyloidosis that… View more
Start date: May 11, 2024 End date: May 14, 2024
The Heart Failure Congress stands as the foremost global event encompassing the entire spectrum of heart failure. Hosted annually by the Heart Failure Association of the ESC, its overarching mission revolves around enhancing the quality of life and longevity. This mission is pursued through advancements in the prevention, diagnosis, and treatment of heart failure, along with the establishment of… View more
Author(s): Mihai Gheorghiade Added: 3 years ago
An episode of acute heart failure syndromes (AHFS) can be defined as a rapid or gradual onset of signs and symptoms of heart failure that result in hospital admission. Over 70% of AHFS events are the result of worsening chronic heart failure.1 Other causes of AHFS include new-onset heart failure due to an acute coronary event, such as a myocardial infarction (MI), and end-stage or refractory… View more
The Heart Rhythm Society (HRS) is a leading resource on cardiac pacing and electrophysiology. This specialty organization represents medical, allied health, and science professionals from more than 70 countries who specialize in cardiac rhythm disorders. Mission: to improve the care of patients by promoting research, education, and optimal health care policies and standards.Vision: to end death… View more
Author(s): Kilmer S McCully Added: 3 years ago
Discovery of the Homocysteine Theory of Arteriosclerosis The American biochemist Vincent DuVigneaud discovered a new amino acid in 1932 by treating methionine with sulfuric acid. The structure of this amino acid is similar to cysteine, except for one extra carbon atom, hence the name homocysteine. Subsequent investigation established the role of homocysteine as an intermediate in sulfur amino… View more
Author(s): Kilmer S McCully Added: 3 years ago
Discovery of the Homocysteine Theory of Arteriosclerosis The American biochemist Vincent DuVigneaud discovered a new amino acid in 1932 by treating methionine with sulfuric acid. The structure of this amino acid is similar to cysteine, except for one extra carbon atom, hence the name homocysteine. Subsequent investigation established the role of homocysteine as an intermediate in sulfur amino… View more
Author(s): Mihai Gheorghiade Added: 3 years ago
An episode of acute heart failure syndromes (AHFS) can be defined as a rapid or gradual onset of signs and symptoms of heart failure that result in hospital admission. Over 70% of AHFS events are the result of worsening chronic heart failure. Other causes of AHFS include new-onset heart failure due to an acute coronary event, such as a myocardial infarction (MI), and end-stage or refractory heart… View more
Author(s): Erik B Friedrich , Michael Böhm Added: 3 years ago
Chronic heart failure (CHF) is a major public health problem in industrialized societies with an incidence approaching 10 per 1,000 population after age 65 and an age-dependent prevalence of less than 1% between ages 45-55, 2-5% between ages 65-75, and approximately 10% for patients aged 80 years or more.Thus, HF is primarily a condition of the elderly and approximately 80% of patients… View more
Author(s): Brian Pearlman , Taffere Mihretu Added: 3 years ago
Congestive heart failure (CHF) is a rapidly growing public health problem, affecting nearly five million people in the US alone, with nearly half a million new cases annually.The prevalence of CHF is highest in the elderly; ten out of every 1,000 persons over age 65 are affected. Anemia has been considered a modifiable comorbidity in heart failure. Utilizing the World Health Organization (WHO)… View more